Endotype-driven interventions in asthma

Endotype-driven interventions in asthma

Differentiation of bronchial epithelial spheroids in the presence of IL-13 recapitulates characteristic features of type 2 asthmatic airway epithelia

The proportions of tezepelumab-treated patients with severe, uncontrolled asthma who achieved twice the minimum clinically important difference in patient-reported outcome measures in the phase 3 NAVIGATOR study

The efficacy of tezepelumab in patients with severe, uncontrolled asthma receiving Global Initiative for Asthma guidelines step 4 or step 5 treatment in the phase 3 NAVIGATOR study

Dupilumab Efficacy In VOYAGE Pediatric Patients With Uncontrolled, Moderate-to-Severe Type 2 Inflammatory Asthma By Allergen Sensitization Status

Dupilumab Long-term Efficacy in Patients With Asthma With or Without Comorbid Chronic Rhinosinusitis/Nasal Polyposis Enrolled in LIBERTY ASTHMA TRAVERSE From Phase 2b study